Clinical use of factor IX concentrates
Nyman, D.
Schweizerische Medizinische Wochenschrift 105(37): 1188-1190
1975
ISSN/ISBN: 0036-7672 PMID: 1215901 Document Number: 95504
Factor IX concentrates are of paramount importance in the treatment of hemophilia B. Growing reports of thromboembolic complications and of disseminated intravascular coagulation, coupled with the danger of hepatitis transmission, suggest that the concentrates should be primarily reserved for the treatment of hemophilia B. Concise guidelines for treatment are presented.
Document emailed within 1 workday
Related Documents
Okamoto, K.; Tamura, T.; Yamaguchi, K. 2011: Clinical trials of anticoagulants and anticoagulant factor concentrates for the management of DIC in Japan Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 95-103Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Lusher, J.M. 1991: Thrombogenicity associated with factor IX complex concentrates Seminars in Hematology 28(3 Suppl 6: 3-5
Mariani, G.; Di Nucci, G.D.; Arcieri, P. 1994: Immunopurified clotting factor concentrates Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S61-S65
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Magner, A.; Aronson, D. 1979: Toxicity of factor IX concentrates in mice Developments in Biological Standardization 44: 185-188
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Rubinstein, D.B. 1995: Virus infection and clotting factor concentrates Lancet 345(8959): 1248
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Lusher, J.M. 1993: Prediction and management of adverse events associated with the use of factor IX complex concentrates Seminars in Hematology 30(2 Suppl. 1): 36-40
Fricke, W.A.; Lamb, M.A.; Rastogi, S.C. 1993: Standards for assay of von Willebrand factor concentrates: a collaborative study Thrombosis and Haemostasis 70(2): 351-356
Prowse, C.V.; Chirnside, A.; Elton, R.A. 1980: In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays Thrombosis and Haemostasis 42(5): 1355-1367
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Rossiter, S.J.; Miller, D.C.; Raney, A.A.; Oyer, P.E.; Reitz, B.A.; Stinson, E.B.; Shumway, N.E. 1979: Hepatitis risk in cardiac surgery patients receiving factor IX concentrates Journal of Thoracic and Cardiovascular Surgery 78(2): 203-207
Brieva, J.A.; Sequi, J.; Zabay, J.M.; Pardo, A.; Campos, A.; Luz de la Sen, M.; Bootello, A. 1985: Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration Clinical and Experimental Immunology 59(2): 491-498
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Rodríguez Bueno, S.; Montoro Ronsano, J.B.; Martínez Sánchez, B.; Altisent Roca, C.; Tusell Puigvert, J.M. 1991: The administration of factor VIIi concentrates to hemophiliacs by continuous perfusion pump Medicina Clinica 96(10): 364-366